Guillain-Barr Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barr é Syndrome (GBS)
Condition: Guillain-Barré Syndrome Interventions: Drug: Crovalimab; Drug: Placebo; Drug: Intravenous immunoglobulin therapy Sponsors: Hoffmann-La Roche; Chugai Pharmaceutical Co., Ltd. (Sponsor in Taiwan and Japan) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
